APA (7th ed.) Citation

Kasar, S., Yuan, Y., Underbayev, C., Vollenweider, D., Hanlon, M., Chang, V., . . . Raveche, E. (2012). Altering microRNA miR15a/16 Levels as Potential Therapy in CLL: Extrapolating from the De Novo NZB Mouse Model. IntechOpen. https://doi.org/10.5772/28685

Chicago Style (17th ed.) Citation

Kasar, Siddha, Yao Yuan, Chingiz Underbayev, Dan Vollenweider, Matt Hanlon, Victor Chang, Hina Khan, and Elizabeth Raveche. Altering MicroRNA MiR15a/16 Levels as Potential Therapy in CLL: Extrapolating from the De Novo NZB Mouse Model. IntechOpen, 2012. https://doi.org/10.5772/28685.

MLA (9th ed.) Citation

Kasar, Siddha, et al. Altering MicroRNA MiR15a/16 Levels as Potential Therapy in CLL: Extrapolating from the De Novo NZB Mouse Model. IntechOpen, 2012. https://doi.org/10.5772/28685.